Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Brainsway Ltd. (BWAY) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"BrainsWay Further Expands Access to Deep TMS™ in Asia Pacific Region"
08/09/2023 6-K Quarterly results
Docs: "FORM 6-K",
"BrainsWay Reports Second Quarter 2023 Financial Results and Operational Highlights"
07/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"BrainsWay Accelerates International Expansion in India"
05/23/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"BrainsWay Announces Appointment of Ido Marom as CFO"
05/17/2023 6-K Quarterly results
Docs: "FORM 6-K",
"BrainsWay Reports First Quarter 2023 Financial Results and Operational Highlights"
03/20/2023 6-K Quarterly results
03/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"BrainsWay Reports Fourth Quarter and Full-Year 2022 Financial Results and Operational Highlights"
02/13/2023 6-K Quarterly results
02/13/2023 6-K Quarterly results
02/13/2023 6-K Quarterly results
01/12/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"BrainsWay Appoints Ami Boehm as Board Member"
01/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"BrainsWay Resolves Neuronetics Litigation"
11/28/2022 6-K Quarterly results
11/16/2022 6-K Quarterly results
09/14/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"BrainsWay Announces Significant Private Insurance Coverage from Cigna Corporation for the Treatment of OCD Utilizing Deep TMS™"
08/29/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"BrainsWay Receives New FDA Clearance for Treating Depression and Anxious Depression Depression Clearance for the Proprietary Deep TMS™ H7 Coil Represents the Company’s 9th FDA Clearance"
08/10/2022 6-K Quarterly results
06/28/2022 6-K Quarterly results
05/11/2022 6-K Quarterly results
03/09/2022 6-K Quarterly results
01/31/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"BrainsWay Announces Final Local Coverage Determination Issued by Regional Medicare Administrative Contractor Palmetto GBA Providing Coverage of Deep TMS™ for the Treatment of OCD"
12/23/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
12/09/2021 6-K Quarterly results
11/17/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Notice and Proxy Statement of Annual Meeting of Shareholders",
"Notice and Proxy Statement of Annual Meeting of Shareholders",
"Proxy Card"
11/17/2021 6-K Quarterly results
Docs: "FORM 6-K",
"BrainsWay Reports Third Quarter 2021 Financial Results and Operational Highlights"
08/18/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"FDA Clears BrainsWay Deep TMS™ System for Decreasing Anxiety Symptoms in Depressed Patients"
08/11/2021 6-K Quarterly results
Docs: "FORM 6-K",
"BrainsWay Reports Second Quarter 2021 Financial Results and Operational Highlights"
06/03/2021 6-K Quarterly results
06/02/2021 6-K Quarterly results
06/01/2021 6-K Quarterly results
05/24/2021 6-K Quarterly results
05/24/2021 6-K Quarterly results
05/20/2021 6-K Quarterly results
05/05/2021 6-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy